Literature DB >> 16502124

Calcium abnormalities of dialysis patients.

Masafumi Fukagawa1, Tadao Akizawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502124     DOI: 10.1007/s00774-005-0663-y

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


× No keyword cloud information.
  3 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.

Authors:  Eric W Young; Justin M Albert; Sudtida Satayathum; David A Goodkin; Ronald L Pisoni; Takashi Akiba; Tadao Akizawa; Kiyoshi Kurokawa; Jürgen Bommer; Luis Piera; Friedrich K Port
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

3.  An overview of regular dialysis treatment in Japan (as of 31 December 2001).

Authors:  Shigeru Nakai; Takahiro Shinzato; Yuji Nagura; Ikuto Masakane; Tateki Kitaoka; Toshio Shinoda; Chikao Yamazaki; Rumi Sakai; Hiroyuki Ohmori; Osamu Morita; Kunitoshi Iseki; Kenjiro Kikuchi; Kazuo Kubo; Kazuyuki Suzuki; Kaoru Tabei; Kiyohide Fushimi; Naoko Miwa; Atsushi Wada; Mitsuru Yanai; Takashi Akiba
Journal:  Ther Apher Dial       Date:  2004-02       Impact factor: 1.762

  3 in total
  4 in total

Review 1.  Regulation of parathyroid function in chronic kidney disease (CKD).

Authors:  Masafumi Fukagawa; Shohei Nakanishi; Hideki Fujii; Yasuhiro Hamada; Takaya Abe
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

Review 2.  The kidney and bone metabolism: Nephrologists' point of view.

Authors:  Masafumi Fukagawa; Yasuhiro Hamada; Shohei Nakanishi; Motoko Tanaka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 3.  CKD-MBD: impact on management of kidney disease.

Authors:  Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

4.  Clinical significance of parathyroid intervention on CKD-MBD management.

Authors:  Hiroaki Ogata; Masahide Mizobuchi; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  NDT Plus       Date:  2008-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.